• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.91% Nasdaq Up 0.81%

    Geron Corporation (GERN)

    -NasdaqGS
    2.26 Up 0.06(2.73%) Sep 30, 4:00PM EDT
    |After Hours : 2.36 Up 0.10 (4.42%) Sep 30, 7:49PM EDT
    Prev Close:2.20
    Open:2.22
    Bid:2.23 x 5000
    Ask:2.45 x 100
    1y Target Est:4.38
    Beta:3.76153
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:2.18 - 2.30
    52wk Range:1.84 - 5.30
    Volume:1,311,010
    Avg Vol (3m):1,782,000
    Market Cap:359.65M
    P/E (ttm):282.50
    EPS (ttm):0.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNUp 2.73%359.65M
    BMYUp 0.09%90.09B
    GSKUp 0.54%102.67B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.23
    Quarterly EPS Est (Sep-16) :-0.06
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-1.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback